In the weeks before Elizabeth Holmes surrendered herself to prison, two filmmakers were granted access that most documentarians never receive — not the reconstructed past, but the unfolding present. The resulting film, 'You Can See Everything,' premiered at Telluride in September 2026, positioning itself not as another chapter in the Theranos mythology but as something rarer: a portrait of a person standing at the threshold between the life they built and the consequences it earned. Distributed by A24, the film asks what we are really looking for when we watch the powerful face their reckoning
Nathan Fielder's Elizabeth Holmes Documentary 'You Can See Everything' Premieres at Telluride
Related Coverage
A young woman nearly dies from poisoning, with investigators focusing on two trusted individuals in her life. CBS News' …
The Guardian · Sep 10 Lambie escalates attack on Hanson over cartoon branding Hastie 'traitor'Jacqui Lambie escalates criticism of Pauline Hanson after One Nation refuses to remove a cartoon labeling SAS veteran An…
upstox.com · Sep 10 Foreign investors return to India but avoid banks amid margin pressuresForeign institutional investors resumed buying Indian equities in July-August after four months of selling, but largely …
Top Gear · Sep 10 Lamborghini Revuelto SV: Track-Focused Hypercar Delivers Outrageous PerformanceTop Gear tests the Lamborghini Revuelto SV prototype, a track-focused variant of the hybrid V12 supercar featuring passi…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
Documentary about Elizabeth Holmes' pre-prison period has no geopolitical implications; this is a cultural/entertainment story unrelated to international relations.
Economic Lens
Documentary about Elizabeth Holmes' pre-prison period has minimal direct economic impact; primarily entertainment/media sector relevance with limited market implications.
Consumers gain educational content about corporate fraud case; potential increased awareness of startup accountability. No direct household economic effects.
May reinforce public discourse around startup regulation, investor protection, and corporate governance oversight. Could influence future regulatory scrutiny of health-tech companies.